Furthermore, while previous studies suggest a higher CTEPH risk with TPO-RAs, these findings are still evolving, and long-term follow-up studies are necessary to clarify the interaction between Eltrombopag, splenectomy, and the risk of CTEPH. This evidence concerns the gene TPO and chronic thromboembolic pulmonary hypertension.